-
1.发明申请METHOD FOR USING PHOTOPLETHYSMOGRAPHY TO OPTIMIZE FLUID REMOVAL DURING RENAL REPLACEMENT THERAPY BY HEMODIALYSIS OR HEMOFILTRATION 审中-公开使用光化学显微镜优化通过肝细胞分析或HEMOFILION治疗的肾移植治疗期间的液体去除的方法公开(公告)号：US20110098545A1
公开(公告)日：2011-04-28
申请号：US12985435
申请日：2011-01-06
IPC分类号： A61B5/1455 , A61B5/024
CPC分类号： A61M1/34 , A61B5/02007 , A61B5/0261 , A61B5/0295 , A61B5/6819 , A61M1/3403 , A61M1/341 , A61M1/3609 , A61M2205/3306 , A61M2205/50
摘要： Disclosed herein are methods, systems and devices to monitor vascular volume status during renal replacement therapy utilizing at least one oximetry/photoplethysmography sensor. The methods, systems and devices provide an alternative to conventional vascular volume monitoring methods during renal replacement therapy while enabling reliable, non-invasive, and automatic monitoring of vascular volume to avert patient hypotension. The methods, systems and devices may be employed in the context of both inpatient and outpatient dialysis facilities and may also be incorporated into conventional hemodialysis and hemofiltration techniques and equipment.
摘要翻译： 本文公开了使用至少一种血氧定量/光电容积描记传感器在肾脏替代治疗期间监测血管体积状态的方法，系统和装置。 在肾脏替代治疗期间，方法，系统和装置提供常规血管容积监测方法的替代方案，同时实现血管容积的可靠，非侵入和自动监测以避免患者低血压。 方法，系统和装置可以在住院和门诊透析设备的上下文中使用，并且还可以并入常规血液透析和血液滤过技术和设备中。
-
公开(公告)号：US6080404A
公开(公告)日：2000-06-27
申请号：US924689
申请日：1997-09-05
CPC分类号： B01D15/00 , B01J20/262 , B01J20/28023 , B01J20/3085 , B01J20/321 , B01J20/3212 , B01J20/3219 , B01J20/3248 , B01J20/3251 , B01J20/3253 , B01J20/3272 , A61M1/3679
摘要： The subject invention concerns novel means for adsorption of materials from fluids. In a specific example, polymer substrates are modified with dendrimers to facilitate attachment of multiple ligands held at a distance from the surface of the substrate.
摘要翻译： 本发明涉及从流体吸附材料的新颖手段。 在具体实例中，用树枝状大分子改性聚合物底物以促进与基底表面保持一定距离的多个配体的附着。
-
3.发明申请METHOD FOR USING PHOTOPLETHYSMOGRAPHY TO OPTIMIZE FLUID REMOVAL DURING RENAL REPLACEMENT THERAPY BY HEMODIALYSIS OR HEMOFILTRATION 有权使用光化学显微镜优化通过肝细胞分析或HEMOFILION治疗的肾移植治疗期间的液体去除的方法公开(公告)号：US20080067132A1
公开(公告)日：2008-03-20
申请号：US11532251
申请日：2006-09-15
IPC分类号： C02F1/00
CPC分类号： A61M1/34 , A61B5/02007 , A61B5/0261 , A61B5/0295 , A61B5/6819 , A61M1/3403 , A61M1/341 , A61M1/3609 , A61M2205/3306 , A61M2205/50
摘要： Disclosed herein are methods, systems and devices to monitor vascular volume status during renal replacement therapy utilizing at least one oximetry/photoplethysmography sensor. The methods, systems and devices provide an alternative to conventional vascular volume monitoring methods during renal replacement therapy while enabling reliable, non-invasive, and automatic monitoring of vascular volume to avert patient hypotension. The methods, systems and devices may be employed in the context of both inpatient and outpatient dialysis facilities and may also be incorporated into conventional hemodialysis and hemofiltration techniques and equipment.
摘要翻译： 本文公开了使用至少一种血氧定量/光电容积描记传感器在肾脏替代治疗期间监测血管体积状态的方法，系统和装置。 在肾脏替代治疗期间，方法，系统和装置提供常规血管容积监测方法的替代方案，同时实现血管容积的可靠，非侵入和自动监测以避免患者低血压。 方法，系统和装置可以在住院和门诊透析设备的上下文中使用，并且还可以并入常规血液透析和血液滤过技术和设备中。
-
4.发明授权Method for using photoplethysmography to optimize fluid removal during renal replacement therapy by hemodialysis or hemofiltration 有权在血液透析或血液滤过肾脏置换治疗期间使用光电容积描记法优化流体去除的方法公开(公告)号：US07887502B2
公开(公告)日：2011-02-15
申请号：US11532251
申请日：2006-09-15
IPC分类号： A61M37/00
CPC分类号： A61M1/34 , A61B5/02007 , A61B5/0261 , A61B5/0295 , A61B5/6819 , A61M1/3403 , A61M1/341 , A61M1/3609 , A61M2205/3306 , A61M2205/50
摘要： Disclosed herein are methods, systems and devices to monitor vascular volume status during renal replacement therapy utilizing at least one oximetry/photoplethysmography sensor. The methods, systems and devices provide an alternative to conventional vascular volume monitoring methods during renal replacement therapy while enabling reliable, non-invasive, and automatic monitoring of vascular volume to avert patient hypotension. The methods, systems and devices may be employed in the context of both inpatient and outpatient dialysis facilities and may also be incorporated into conventional hemodialysis and hemofiltration techniques and equipment.
摘要翻译： 本文公开了使用至少一种血氧定量/光电容积描记传感器在肾脏替代治疗期间监测血管体积状态的方法，系统和装置。 在肾脏替代治疗期间，方法，系统和装置提供常规血管容积监测方法的替代方案，同时实现血管容积的可靠，非侵入和自动监测以避免患者低血压。 方法，系统和装置可以在住院和门诊透析设备的上下文中使用，并且还可以并入常规血液透析和血液滤过技术和设备中。
-
5.发明授权Method for using photoplethysmography to optimize fluid removal during renal replacement therapy by hemodialysis or hemofiltration 有权在血液透析或血液滤过肾脏置换治疗期间使用光电容积描记法优化流体去除的方法公开(公告)号：US09155826B2
公开(公告)日：2015-10-13
申请号：US12985435
申请日：2011-01-06
IPC分类号： A61M37/00 , A61B5/00 , A61M1/34 , A61B5/02 , A61B5/026 , A61B5/0295 , A61M1/36 , A61M5/00 , A61B1/00 , A61B5/04
CPC分类号： A61M1/34 , A61B5/02007 , A61B5/0261 , A61B5/0295 , A61B5/6819 , A61M1/3403 , A61M1/341 , A61M1/3609 , A61M2205/3306 , A61M2205/50
摘要： Disclosed herein are methods, systems and devices to monitor vascular volume status during renal replacement therapy utilizing at least one oximetry/photoplethysmography sensor. The methods, systems and devices provide an alternative to conventional vascular volume monitoring methods during renal replacement therapy while enabling reliable, non-invasive, and automatic monitoring of vascular volume to avert patient hypotension. The methods, systems and devices may be employed in the context of both inpatient and outpatient dialysis facilities and may also be incorporated into conventional hemodialysis and hemofiltration techniques and equipment.
摘要翻译： 本文公开了使用至少一种血氧定量/光电容积描记传感器在肾脏替代治疗期间监测血管体积状态的方法，系统和装置。 在肾脏替代治疗期间，方法，系统和装置提供常规血管容积监测方法的替代方案，同时实现血管容积的可靠，非侵入和自动监测以避免患者低血压。 方法，系统和装置可以在住院和门诊透析设备的上下文中使用，并且还可以并入常规血液透析和血液滤过技术和设备中。
-
6.发明授权公开(公告)号：US07530962B2
公开(公告)日：2009-05-12
申请号：US11422891
申请日：2006-06-08
CPC分类号： A61M1/3621 , A61M1/3656 , A61M1/3669 , A61M2205/13
摘要： The present invention describes a system, apparatus, and method for detection of disconnection of a device from a patient, such as dislodgment of a device during medical treatments or therapies, using a patient's electrical voltages.
摘要翻译： 本发明描述了一种系统，装置和方法，用于使用患者的电压来检测装置与患者之间的断开，例如医疗处理或治疗期间装置的脱离。
-
公开(公告)号：US06869412B2
公开(公告)日：2005-03-22
申请号：US10054483
申请日：2001-11-13
申请人： Edward Allan Ross
发明人： Edward Allan Ross
CPC分类号： A61M1/1678 , A61M1/34 , A61M1/3403 , A61M1/341 , A61M2205/3331
摘要： Plasma fluid removal is needed in a variety of clinical conditions including congestive heart failure and moderate renal insufficiency. In order to avoid the problems inherent in extracorporeal ultrafiltration methods, the present invention removes fluid using an intravascular or intracorporeal dual-lumen catheter. Plasma fluid is driven across a semipermeable membrane, as in an in vivo vascular catheter. Suboptimal intracatheter flow, luminal collapse, erratic high transmembrane flow with nonhomogenous caking and clotting of the external catheter surface are all avoided by inducing pressure gradients across the wall by means of osmotic forces instead of negative pressures induced by hydraulic pumps. Osmotically induced fluid flow would tend to keep the lumena slightly distended and thereby simplify the fluid delivery systems. Osmotic gradients are maintained by utilizing dual lumen catheters typically placed in large central veins, and attached to pumps supplying high osmolality sterile solutions (such as dextrose or other sugars). Such a sealed system using readily available sterile sugar solutions and biocompatible catheter substrate would be extremely safe.
摘要翻译： 在各种临床状况下需要等离子体液体去除，包括充血性心力衰竭和中度肾功能不全。 为了避免体外超滤方法中固有的问题，本发明使用血管内或体内双腔导管去除流体。 等离子体流体通过半透膜被驱动，如在体内血管导管中。 通过渗透压力而不是由液压泵引起的负压通过渗透压力引起压力梯度，都可以避免不适当的内部管腔流动，管腔崩溃，不均匀的高跨膜流动与外部导管表面的非均匀结块和凝结。 渗透诱导的流体流动将倾向于保持腔体稍微膨胀，从而简化流体输送系统。 通过使用通常放置在大的中央静脉中的双腔导管来维持渗透性梯度，并且连接到供应高渗透压浓度的无菌溶液（例如葡萄糖或其它糖）的泵上。 使用容易获得的无菌糖溶液和生物相容性导管基质的这种密封系统将是非常安全的。
-
8.发明授权公开(公告)号：US06360588B1
公开(公告)日：2002-03-26
申请号：US09448634
申请日：1999-11-24
申请人： Edward Allan Ross , Ian R. Tebbett , Charles J. Schmidt , Timothy Patrick Griffin , Margaret Wheland Couch
发明人： Edward Allan Ross , Ian R. Tebbett , Charles J. Schmidt , Timothy Patrick Griffin , Margaret Wheland Couch
IPC分类号： G01N1508
CPC分类号： H01J49/0436 , G01N13/04 , G01N15/0826 , G01N30/7233 , G01N2015/084 , G01N2030/027
摘要： The subject invention pertains to the efficient and accurate detection and analysis of materials passing through a membrane. In a specific example the transport of materials through skin is analyzed. The subject method can allow accurate, precise, and specific real time measurements of compounds crossing a membrane. Accordingly, the subject method can save time in product development of pharmaceuticals, cosmetics, and protective clothing products, and can also reduce the need for animal and human testing.
摘要翻译： 本发明涉及通过膜的材料的有效和准确的检测和分析。 在具体实例中分析材料通过皮肤的运输。 主题方法可以准确，精确和具体地实时测量跨越膜的化合物。 因此，本发明方法可以节省药物，化妆品和防护服产品的产品开发时间，并且还可以减少动物和人体测试的需要。
-
公开(公告)号：US20100237011A1
公开(公告)日：2010-09-23
申请号：US12408353
申请日：2009-03-20
CPC分类号： A61M1/3413 , A61M1/168 , A61M1/1682 , A61M1/3643 , A61M1/3644 , A61M1/3649 , A61M2205/3331 , A61M2205/7554
摘要： This disclosure relates to blood treatment systems and related methods. The systems can include a blood pump arranged to move blood through a blood filter, a pressure sensor arranged to measure pressure of blood flowing through a fluid line between the blood pump and the blood filter, and a controller configured to activate a rinse pump to move rinse fluid through the blood filter based at least in part on the pressure of blood flowing through the fluid line as measured by the pressure sensor.
摘要翻译： 本公开涉及血液处理系统及相关方法。 所述系统可以包括布置成通过血液过滤器移动血液的血液泵，布置成测量流过血液泵和血液过滤器之间的流体管线的血液的压力的压力传感器，以及被配置为激活冲洗泵移动的控制器 至少部分地基于由压力传感器测量的流过流体管线的血液的压力，通过血液过滤器冲洗流体。
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.018 秒)
